AN2 Therapeutics, Inc. Insider Transactions
AN2 Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Eizen Joshua M
See Remarks |
Sell | 2,819 @ $1.14 | $3.21 K | 177,353 | 11/04/2025 | 11/06/2025 | |
|
Prior Stephen David
Chief Strategy Officer |
Sell | 765 @ $1.14 | $872 | 65,548 | 11/04/2025 | 11/06/2025 | |
|
Easom Eric
CEO |
Buy | 10,000 @ $1.07 | $10.67 K | 256,380 | 06/02/2025 | 06/03/2025 | |
|
Leonard Braden Michael
10 percent owner |
Sell | 425,000 @ $1.01 | $429.25 K | 3,224,432 | 05/30/2025 | 05/30/2025 | |
|
Leonard Braden Michael
10 percent owner |
Sell | 7,000 @ $1.03 | $7.23 K | 3,217,432 | 05/30/2025 | 05/30/2025 | |
|
Leonard Braden Michael
10 percent owner |
Sell | 2,000,000 @ $1.16 | $2.32 M | 3,749,432 | 05/28/2025 | 05/30/2025 | |
|
Leonard Braden Michael
10 percent owner |
Sell | 100,000 @ $1.16 | $116.00 K | 3,649,432 | 05/28/2025 | 05/30/2025 | |
|
Leonard Braden Michael
10 percent owner |
Sell | 200,000 @ $1.09 | $218.00 K | 3,017,432 | 05/28/2025 | 06/16/2025 | |
|
FitzPatrick Margaret M
Director |
Buy | 8,610 @ $1.18 | $10.13 K | 8,610 | 05/28/2025 | 05/29/2025 | |
|
Eizen Joshua M
See Remarks |
Sell | 9,663 @ $1.34 | $12.96 K | 116,672 | 01/03/2025 | 01/07/2025 | |
|
Day Lucy
CFO |
Sell | 2,957 @ $1.34 | $3.97 K | 32,670 | 01/03/2025 | 01/07/2025 | |
|
Chanda Sanjay
Chief Development Officer |
Sell | 2,957 @ $1.34 | $3.97 K | 29,824 | 01/03/2025 | 01/07/2025 | |
|
Prior Stephen David
Chief Strategy Officer |
Sell | 2,029 @ $1.34 | $2.72 K | 33,313 | 01/03/2025 | 01/07/2025 | |
|
Readnour Robin Shane
Director |
Buy | 5,000 @ $1.49 | $7.46 K | 582,288 | 12/10/2024 | 12/10/2024 | |
|
Readnour Robin Shane
Director |
Buy | 18,483 @ $1.43 | $26.41 K | 647,573 | 12/09/2024 | 12/10/2024 | |
|
Readnour Robin Shane
Director |
Buy | 12,289 @ $1.43 | $17.58 K | 577,288 | 12/09/2024 | 12/10/2024 | |
|
Readnour Robin Shane
Director |
Buy | 12,711 @ $1.45 | $18.37 K | 564,999 | 12/06/2024 | 12/10/2024 | |
|
Readnour Robin Shane
Director |
Buy | 6,517 @ $1.45 | $9.43 K | 629,090 | 12/06/2024 | 12/10/2024 | |
|
Readnour Robin Shane
Director |
Buy | 25,000 @ $1.42 | $35.42 K | 622,573 | 11/27/2024 | 11/27/2024 | |
|
Zakrzewski Joseph S
Director |
Buy | 2,000 @ $1.40 | $2.80 K | 125,199 | 11/27/2024 | 11/27/2024 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
AN2 Therapeutics, Inc. FAQ's
The list of insiders at AN2 Therapeutics, Inc. includes Readnour Robin Shane, Day Lucy, Chanda Sanjay, Prior Stephen David, Eizen Joshua M, Leonard Braden Michael, FitzPatrick Margaret M, Easom Eric.
Insiders have sold a total of 2.75 M AN2 Therapeutics, Inc. shares in the last 12 months for a total of 3.12 M sold.
The following insiders have sold AN2 Therapeutics, Inc. shares in the last 12 months: Day Lucy ($3.97 K), Chanda Sanjay ($3.97 K), Prior Stephen David ($3.59 K), Eizen Joshua M ($16.17 K), Leonard Braden Michael ($3.09 M),
Insiders have purchased a total of 73.61 K AN2 Therapeutics, Inc. shares in the last 12 months for a total of 100.04 K.
The following insiders have purchased AN2 Therapeutics, Inc. shares in the last 12 months: Readnour Robin Shane ($79.24 K), FitzPatrick Margaret M ($10.13 K), Easom Eric ($10.67 K),